Maravai LifeSciences Q2 Sales $68.91M Miss $70.30M Estimate
Portfolio Pulse from sunil@benzinga.com
Maravai LifeSciences reported Q2 sales of $68.91 million, missing the analyst consensus estimate of $70.30 million by 1.97 percent. This represents a 71.61 percent decrease from the same period last year.
August 07, 2023 | 8:36 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Maravai LifeSciences' Q2 sales missed estimates and showed a significant decrease from last year.
Maravai LifeSciences' Q2 sales missed the analyst consensus estimate and decreased significantly from the same period last year. This could negatively impact investor sentiment and potentially lead to a decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100